Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 331 AL 345

Impact of corticoid receptors on Alzheimer's disease: a neuroendocrine perspective

Goel F, Kumar D, Sharma A.

Inflammopharmacology. 2025 May;33(5):2641-2656. doi: 10.1007/s10787-025-01734-w. Epub 2025 Apr 18.

NLRP3 inflammasome in Alzheimer's disease: molecular mechanisms and emerging therapies

Li Z, Gong C.

Front Immunol. 2025 Apr 7;16:1583886. doi: 10.3389/fimmu.2025.1583886. eCollection 2025.

Butyrate: a key mediator of gut-brain communication in Alzheimer's disease

Kachoueiyan F, Kalkhoran NY, Kalkhoran AY, Kyada A, Rekha MM, Chaudhary K, Barwal A, Sead FF, Joshi KK.

Metab Brain Dis. 2025 Apr 23;40(5):189. doi: 10.1007/s11011-025-01617-7.

Apolipoprotein E in Alzheimer's disease: molecular insights and therapeutic opportunities

Belaidi AA, Bush AI, Ayton S.

Mol Neurodegener. 2025 Apr 24;20(1):47. doi: 10.1186/s13024-025-00843-y.

Molecular dynamics of amyloid-β transport in Alzheimer's disease: Exploring therapeutic plasma exchange with albumin replacement - Current insights and future perspectives

Mondal R, Deb S, Shome G, Sarkar V, Lahiri D, Datta SS, Benito-León J.

Neurologia (Engl Ed). 2025 Apr;40(3):306-328. doi: 10.1016/j.nrleng.2025.03.008.

Extracellular vesicles as therapeutic modulators of neuroinflammation in Alzheimer's disease: a focus on signaling mechanisms

Han J, Zhang X, Kang L, Guan J.

J Neuroinflammation. 2025 Apr 25;22(1):120. doi: 10.1186/s12974-025-03443-1.

Iatrogenic Dementia: Providing Insight into Transmissible Subtype of Alzheimer's Disease, Creutzfeldt-Jakob Disease and Cerebral Amyloid Angiopathy

Karatzetzou S, Ioannidis S, Konstantinopoulou E, Parisis D, Afrantou T, Ioannidis P.

Biomolecules. 2025 Apr 3;15(4):522. doi: 10.3390/biom15040522.

Role of Ion Channels in Alzheimer's Disease Pathophysiology

Bhoi R, Mitra T, Tejaswi K, Manoj V, Ghatak S.

J Membr Biol. 2025 Jun;258(3):187-212. doi: 10.1007/s00232-025-00341-8. Epub 2025 May 1.

Small molecule-mediated therapeutic approaches to target Tau and Alzheimer's disease

Chinnathambi S.

Adv Protein Chem Struct Biol. 2025;145:287-304. doi: 10.1016/bs.apcsb.2024.11.010. Epub 2024 Dec 5.

Insights into the intramembrane protease SPPL2b and its substrates: Functions and disease implications

Badman J, Parracino A, Kumar R, Tambaro S.

Sci Signal. 2025 May 6;18(885):eadt2272. doi: 10.1126/scisignal.adt2272. Epub 2025 May 6.

The involvement of the cholinergic system in Alzheimer disease

Cuello AC.

Handb Clin Neurol. 2025;211:63-79. doi: 10.1016/B978-0-443-19088-9.00005-6.

Amyloid immunotherapy for Alzheimer's disease: the case for cautious adoption

Schott JM, Marshall CR.

Arq Neuropsiquiatr. 2025 May;83(5):1-4. doi: 10.1055/s-0045-1807718. Epub 2025 May 9.

Advances in diagnostic imaging of the glial lymphatic system in Alzheimer's Disease

Mi F, Yang X, Huang X, Xu G, Pan D, Yu C.

Brain Res Bull. 2025 Jul;227:111377. doi: 10.1016/j.brainresbull.2025.111377. Epub 2025 May 9.

Mouse models of Anti-Aβ immunotherapies

Pikus P, Turner RS, Rebeck GW.

Mol Neurodegener. 2025 May 13;20(1):57. doi: 10.1186/s13024-025-00836-x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias